BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7219053)

  • 1. Synthesis and renal function study of Val-Asp-(Arg8)-vasopressin.
    Chan YL; Peterson CA; Ting YF; Smith CW
    Life Sci; 1981 Jan; 28(4):415-9. PubMed ID: 7219053
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and renal effects of Ala-Gly-[Arg8]-vasopressin.
    Chan YL; Smith CW
    Biochem Biophys Res Commun; 1980 Sep; 96(2):626-31. PubMed ID: 7426004
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of isoproterenol on renal function.
    Zahajszky T; Fejes-Tóth G; Filep J
    Acta Physiol Acad Sci Hung; 1982; 59(3):197-202. PubMed ID: 7168339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of arginine vasopressin antagonist on renal water excretion in glucocorticoid and mineralocorticoid deficient rats.
    Ishikawa S; Schrier RW
    Kidney Int; 1982 Dec; 22(6):587-93. PubMed ID: 7162034
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis of 8-D-arginine vasopressin analogues, modified in position 1 as antagonists of the vasopressor response to the parent hormone.
    Lammek B; Derdowska I; Melin P
    Pol J Pharmacol Pharm; 1988; 40(4):423-8. PubMed ID: 3222181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Proline and 4-hydroxyproline analogs of arginine vasopressin: role of the proline substitution in the two beta-turns of vasopressin.
    Buku A; Yamin N; Gazis D
    Experientia; 1987 Dec; 43(11-12):1218-9. PubMed ID: 3691742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response effects of pressor doses of arginine vasopressin on renal haemodynamics in the rat.
    McVicar AJ
    J Physiol; 1988 Oct; 404():535-46. PubMed ID: 3253442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of potent and selective antagonists of the vasopressor responses to arginine-vasopressin.
    Manning M; Lammek B; Kruszynski M; Seto J; Sawyer WH
    J Med Chem; 1982 Apr; 25(4):408-14. PubMed ID: 7069719
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal mechanisms of human alpha-atrial natriuretic peptide in man.
    Brown J; Corr L
    J Physiol; 1987 Jun; 387():31-46. PubMed ID: 2958623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal diuresis and antidiuresis after injections of arginine vasotocin in the freshwater eel (Anguilla anguilla L.).
    Henderson IW; Wales NA
    J Endocrinol; 1974 Jun; 61(3):487-500. PubMed ID: 4835434
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of furosemide and d-1-propranolol on glomerular filtration and renin secretin in rats].
    Bonvalet JP; Menard J
    J Urol Nephrol (Paris); 1975; 81(4-5):320-5. PubMed ID: 1159891
    [No Abstract]   [Full Text] [Related]  

  • 12. Design of more potent and selective antagonists of the antidiuretic responses to arginine-vasopressin devoid of antidiuretic agonism.
    Manning M; Klis WA; Olma A; Seto J; Sawyer WH
    J Med Chem; 1982 Apr; 25(4):414-9. PubMed ID: 7069720
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological effects of urotensins. II. Renal effects of urotensin I in the rat.
    Medakovic M; Chan DK; Lederis K
    Pharmacology; 1975; 13(5):419-26. PubMed ID: 1208644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further in vivo evidence for antagonist-to-antidiuretic action of arginine vasopressin.
    Ishikawa S; Kim JK; Schrier RW
    Am J Physiol; 1983 Nov; 245(5 Pt 1):R713-9. PubMed ID: 6688929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [1-beta-Mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine ]argine-vasopressin and [1-beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)]argine-vasopressine, two highly potent antagonists of the vasopressor response to arginine-vasopressin.
    Kruszynski M; Lammek B; Manning M; Seto J; Haldar J; Sawyer WH
    J Med Chem; 1980 Apr; 23(4):364-8. PubMed ID: 6892930
    [No Abstract]   [Full Text] [Related]  

  • 16. Renal escape from vasopressin: role of pressure diuresis.
    Hall JE; Montani JP; Woods LL; Mizelle HL
    Am J Physiol; 1986 May; 250(5 Pt 2):F907-16. PubMed ID: 3706542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of three NH2-terminally extended arginine-vasopressins with prolonged biological activities.
    Lammek B; Rekowski P; Kupryszewski G; Melin P; Ragnarsson U
    Experientia; 1987 Dec; 43(11-12):1211-2. PubMed ID: 3691740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activities of arginine-vasopressin analogues designed from a conformation-activity approach.
    Botos CR; Smith CW; Chan YL; Walter R
    J Med Chem; 1979 Aug; 22(8):926-31. PubMed ID: 490538
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of dopamine and dobutamine on renal function in normal rats].
    Rocha AS; da Silva ZF; Campos SB; Onuchic LF
    Arq Bras Cardiol; 1988 Sep; 51(3):211-6. PubMed ID: 3251447
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of atrial natriuretic factor on blood pressure and renal function of long-term hypothyroid rats.
    Capasso G; Giordano DR; Capodicasa G; DeSanto NG
    Kidney Int Suppl; 1988 Sep; 25():S104-9. PubMed ID: 2972862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.